Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, despite the gray skies hovering over the soggy Pharmalot campus. This is because our spirits remain sunny. As you know, every brand new day should be unwrapped like a precious gift (hat tip to The Morning Mayor). To celebrate, yes, it is time for more cups of stimulation. Meanwhile, here are some items of interest. Hope you conquer the world today …

The Federal Trade Commission settled claims Endo International violated antitrust laws by reaching pay-to-delay agreements with rivals to thwart competition. The agency also filed complaints against Watson Laboratories, its former parent Allergan, and Impax Laboratories over deals that delayed the release of generic versions of the Lidoderm and Opana ER pain relievers in order to maintain a monopoly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!